$コーメディックス(CRMD.US)$CorMedix: TDAPA Program Provides for Five Years Additional Payment Reimbursement >CRMD Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD Dow Jones· 2 mins ago
Trytosaveabit :
Yeah i didn’t even bother posting the approval when I seen late last night until 7am this morning that almost a million shares were borrowed! I knew that it would get a pop then get shorted to the basement! Just like a few that get approved that have been on calendar for a while! It’s like shorts borrow all the shares just before the meeting/approval, let it go up a bit after and then short the hell out of it? ARDX was another they did the same thing to! Hope you were in early and secured profits? GL today
$コーメディックス(CRMD.US)$And this statement gives me a warm fuzzy feeling! Hehehe! (. The company said increased spending from this quarter over last because the company is currently preparing for the potential commercial launch of its lead product, DefenCath
コーメディックスに関するコメント
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
まだコメントはありません